Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

1454 ARTÍCULOS , VIENDO DEL 331 AL 345

Amyloid precursor protein and neural development

Nicolas M, Hassan BA.

Development. 2014 Jul;141(13):2543-8. doi: 10.1242/dev.108712.

Epidemiologic studies of modifiable factors associated with cognition and dementia: systematic review and meta-analysis

Beydoun MA, Beydoun HA, Gamaldo AA, Teel A, Zonderman AB, Wang Y.

BMC Public Health. 2014 Jun 24;14:643. doi: 10.1186/1471-2458-14-643.

Epigenetic regulation of adult neural stem cells: implications for Alzheimer's disease

Fitzsimons CP, van Bodegraven E, Schouten M, Lardenoije R, Kompotis K, Kenis G, van den Hurk M, Boks MP, Biojone C, Joca S, Steinbusch HW, Lunnon K, Mastroeni DF, Mill J, Lucassen PJ, Coleman PD, van den Hove DL, Rutten BP.

Mol Neurodegener. 2014 Jun 25;9:25. doi: 10.1186/1750-1326-9-25.

Effect of metals on kinetic pathways of amyloid-β aggregation

Hane F, Leonenko Z.

Biomolecules. 2014 Jan 10;4(1):101-16. doi: 10.3390/biom4010101.

Dietary fat composition and dementia risk

Morris MC, Tangney CC.

Neurobiol Aging. 2014 Sep;35 Suppl 2:S59-64. doi: 10.1016/j.neurobiolaging.2014.03.038. Epub 2014 May 15.

Add-on prolonged-release melatonin for cognitive function and sleep in mild to moderate Alzheimer's disease: a 6-month, randomized, placebo-controlled, multicenter trial

Wade AG, Farmer M, Harari G, Fund N, Laudon M, Nir T, Frydman-Marom A, Zisapel N.

Clin Interv Aging. 2014 Jun 18;9:947-61. doi: 10.2147/CIA.S65625. eCollection 2014.

Apolipoprotein E and lipid homeostasis in the etiology and treatment of sporadic Alzheimer's disease

Poirier J, Miron J, Picard C, Gormley P, Théroux L, Breitner J, Dea D.

Neurobiol Aging. 2014 Sep;35 Suppl 2(Suppl 2):S3-10. doi: 10.1016/j.neurobiolaging.2014.03.037. Epub 2014 May 15.

Proteoglycans and glycosaminoglycans in misfolded proteins formation in Alzheimer's disease

Wang P, Ding K.

Protein Pept Lett. 2014;21(10):1048-56. doi: 10.2174/0929866521666140626095145.

Amyloid-directed monoclonal antibodies for the treatment of Alzheimer's disease: the point of no return?

Panza F, Solfrizzi V, Imbimbo BP, Logroscino G.

Expert Opin Biol Ther. 2014 Oct;14(10):1465-76. doi: 10.1517/14712598.2014.935332. Epub 2014 Jun 30.

Safety profile of semagacestat, a gamma-secretase inhibitor: IDENTITY trial findings

Henley DB, Sundell KL, Sethuraman G, Dowsett SA, May PC.

Curr Med Res Opin. 2014 Oct;30(10):2021-32. doi: 10.1185/03007995.2014.939167. Epub 2014 Jul 14.

Comparison of (123)I-MIBG myocardial scintigraphy, brain perfusion SPECT, and voxel-based MRI morphometry for distinguishing between dementia with Lewy bodies and Alzheimer's disease

Inui Y, Toyama H, Manabe Y, Sarai M, Iwata N.

Ann Nucl Med. 2014 Oct;28(8):796-804. doi: 10.1007/s12149-014-0873-2. Epub 2014 Jul 2.

Epigenetic drug discovery for Alzheimer's disease

Cacabelos R, Torrellas C.

Expert Opin Drug Discov. 2014 Sep;9(9):1059-86. doi: 10.1517/17460441.2014.930124. Epub 2014 Jul 3.

Distinct perfusion patterns in Alzheimer's disease, frontotemporal dementia and dementia with Lewy bodies

Binnewijzend MA, Kuijer JP, van der Flier WM, Benedictus MR, Möller CM, Pijnenburg YA, Lemstra AW, Prins ND, Wattjes MP, van Berckel BN, Scheltens P, Barkhof F.

Eur Radiol. 2014 Sep;24(9):2326-33. doi: 10.1007/s00330-014-3172-3. Epub 2014 Jul 5.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias